Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3077% above fair value
$59.28−0.74 (-1.23%)
Close on Nov 17, 2026Market cap $2.04BP/E 40.3Yield –
Ingevity total assets
Total assets on the balance sheet at the end of each period.
Ingevity's total assets was $1.54B at Jun 30, 2026. For fiscal 2025 it was $1.65B, down 18.4% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $2.74B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.65B | -18.4% |
| FY2024 | Dec 31, 2024 | $2.02B | -22.9% |
| FY2023 | Dec 31, 2023 | $2.62B | -4.1% |
| FY2022 | Dec 31, 2022 | $2.74B | +10.8% |
| FY2021 | Dec 31, 2021 | $2.47B | +5.8% |
| FY2020 | Dec 31, 2020 | $2.33B | +9.0% |
| FY2019 | Dec 31, 2019 | $2.14B | +62.8% |
| FY2018 | Dec 31, 2018 | $1.32B | +41.5% |
| FY2017 | Dec 31, 2017 | $929.60M | +11.6% |
| FY2016 | Dec 31, 2016 | $832.80M | +6.9% |
| FY2015 | Dec 31, 2015 | $778.70M | +8.6% |
| FY2014 | Dec 31, 2014 | $717.30M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.54B | -18.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.65B | -19.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.65B | -18.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.83B | -17.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.88B | -17.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.06B | -19.9% |
| Q4 FY2024 | Dec 31, 2024 | $2.02B | -22.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.21B | -20.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.28B | -19.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.57B | -7.4% |
| Q4 FY2023 | Dec 31, 2023 | $2.62B | -4.1% |
| Q3 FY2023 | Sep 30, 2023 | $2.77B | +18.5% |
| Q2 FY2023 | Jun 30, 2023 | $2.83B | +19.5% |
| Q1 FY2023 | Mar 31, 2023 | $2.77B | +12.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.74B | +10.8% |
| Q3 FY2022 | Sep 30, 2022 | $2.34B | -3.7% |
| Q2 FY2022 | Jun 30, 2022 | $2.37B | -1.0% |
| Q1 FY2022 | Mar 31, 2022 | $2.46B | +4.8% |
| Q4 FY2021 | Dec 31, 2021 | $2.47B | +5.8% |
| Q3 FY2021 | Sep 30, 2021 | $2.43B | +7.4% |
| Q2 FY2021 | Jun 30, 2021 | $2.39B | +8.8% |
| Q1 FY2021 | Mar 31, 2021 | $2.34B | -0.5% |
| Q4 FY2020 | Dec 31, 2020 | $2.33B | +9.0% |
| Q3 FY2020 | Sep 30, 2020 | $2.26B | +6.6% |
| Q2 FY2020 | Jun 30, 2020 | $2.20B | +3.1% |
| Q1 FY2020 | Mar 31, 2020 | $2.35B | +11.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.14B | +62.8% |
| Q3 FY2019 | Sep 30, 2019 | $2.12B | +64.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.13B | +62.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.11B | +68.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.32B | +41.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.29B | +42.0% |
| Q2 FY2018 | Jun 30, 2018 | $1.31B | +50.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.25B | +45.6% |
| Q4 FY2017 | Dec 31, 2017 | $929.60M | +11.6% |
| Q3 FY2017 | Sep 30, 2017 | $909.80M | +7.6% |
| Q2 FY2017 | Jun 30, 2017 | $874.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $861.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $832.80M | – |
| Q3 FY2016 | Sep 30, 2016 | $845.40M | – |
See a number that looks wrong?